期刊文献+

纳米载药系统逆转肿瘤及骨肉瘤多药耐药的研究进展 被引量:4

Progress on nano-sized drug delivery system reversing tumor and multidrug resistance of osteosarcoma
下载PDF
导出
摘要 多药耐药是肿瘤化疗中的重要难题,多药耐药的机制复杂,目前尚无有效的治疗策略。纳米载药系统具有靶向性、载药种类多样等优点,近年来成为对抗肿瘤多药耐药的递药载体的重要研究方向。对肿瘤抑制的不同机制进行讨论,并对纳米载药系统逆转骨肉瘤多药耐药的研究进展进行综述。 Multidrug resistance(MDR)of tumor cell is the major problem for chemotherapy.However,there is no effective strategy to overcome MDR due to the complicated mechanism.The nano-sized drug delivery system could target to the tumor cell.Moreover,it could delivery different kinds of drugs.Therefore,the nano-sized drug delivery system has become a promising approach to reverse MDR.The nano-sized drug delivery system which is applied to treat the MDR of tumor(osteosarcoma)was summarized and the reverse mechanism was discussed.
出处 《药学实践杂志》 CAS 2016年第2期103-105,共3页 Journal of Pharmaceutical Practice
关键词 肿瘤 骨肉瘤 多药耐药 纳米载药系统 tumor osteosarcoma MDR nano-sized drug delivery system
  • 相关文献

同被引文献34

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部